Model evaluation of continuous data pharmacometric models: metrics and graphics THT Nguyen, MS Mouksassi, N Holford, N Al‐Huniti, I Freedman, ... CPT: pharmacometrics & systems pharmacology 6 (2), 87-109, 2017 | 329 | 2017 |
Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs. JM Borghardt, B Weber, A Staab, C Kloft The AAPS Journal, 2015 | 97 | 2015 |
In vivo evaluation of chitosan as an adjuvant in subcutaneous vaccine formulations R Scherließ, S Buske, K Young, B Weber, T Rades, S Hook Vaccine 31 (42), 4812-4819, 2013 | 96 | 2013 |
A pharmacokinetic simulation tool for inhaled corticosteroids B Weber, G Hochhaus The AAPS journal 15, 159-171, 2013 | 86 | 2013 |
Model evaluation group of the international society of pharmacometrics (ISoP) best practice committee TH Nguyen, MS Mouksassi, N Holford, N Al-Huniti, I Freedman, ... Model evaluation of continuous data pharmacometric models: metrics and …, 2017 | 42 | 2017 |
Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach JM Borghardt, B Weber, A Staab, C Kunz, S Formella, C Kloft British Journal of Clinical Pharmacology 81 (3), 538-552, 2016 | 39 | 2016 |
Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis FK Hurtado, B Weber, H Derendorf, G Hochhaus, T Dalla Costa Antimicrobial agents and chemotherapy 58 (2), 678-686, 2014 | 35 | 2014 |
Pharmacokinetic evaluation of visnagin and Ammi visnaga aqueous extract after oral administration in rats KG Haug, B Weber, G Hochhaus, V Butterweck Planta medica 78 (17), 1831-1836, 2012 | 21 | 2012 |
Industrial Perspective on the Benefits Realized From the FDA’s Model‐Informed Drug Development Paired Meeting Pilot Program GR Galluppi, S Brar, L Caro, Y Chen, N Frey, HP Grimm, DJ Rudd, CC Li, ... Clinical Pharmacology and Therapeutics 110 (5), 1172, 2021 | 20 | 2021 |
Budesonide and ciclesonide: effect of tissue binding on pulmonary receptor binding K Wu, AL Blomgren, K Ekholm, B Weber, S Edsbaecker, G Hochhaus Drug metabolism and disposition 37 (7), 1421-1426, 2009 | 20 | 2009 |
Model‐based evaluation of pulmonary pharmacokinetics in asthmatic and COPD patients after oral olodaterol inhalation JM Borghardt, B Weber, A Staab, C Kunz, C Kloft British journal of clinical pharmacology 82 (3), 739-753, 2016 | 17 | 2016 |
A systematic analysis of the sensitivity of plasma pharmacokinetics to detect differences in the pulmonary performance of inhaled fluticasone propionate products using a model … B Weber, G Hochhaus The AAPS journal 17, 999-1010, 2015 | 17 | 2015 |
A stability analysis of a modified version of the chi-square ratio statistic: implications for equivalence testing of aerodynamic particle size distribution B Weber, G Hochhaus, W Adams, R Lionberger, B Li, Y Tsong, SL Lee The AAPS journal 15, 1-9, 2013 | 16 | 2013 |
Nonlinear pharmacokinetics of visnagin in rats after intravenous bolus administration KG Haug, B Weber, G Hochhaus, V Butterweck European journal of pharmaceutical sciences 45 (1-2), 79-89, 2012 | 16 | 2012 |
Pharmacokinetics of tiotropium administered by respimat® in asthma patients: analysis of pooled data from phase II and III clinical trials A Sharma, HAM Kerstjens, R Aalbers, P Moroni-Zentgraf, B Weber, ... Pulmonary pharmacology & therapeutics 42, 25-32, 2017 | 14 | 2017 |
Population Pharmacokinetic Analysis of Tiotropium in Healthy Volunteers after Intravenous Administration and Inhalation. Parra-Guillen Z, W B, S A, F J, B JM, R S, T IF J Pharmacokinet Pharmacodyn 41, S7-S101, 2014 | 14 | 2014 |
A sensitivity analysis of the modified chi-square ratio statistic for equivalence testing of aerodynamic particle size distribution B Weber, SL Lee, R Lionberger, BV Li, Y Tsong, G Hochhaus The AAPS journal 15, 465-476, 2013 | 13 | 2013 |
Exposure–safety analyses of nintedanib in patients with chronic fibrosing interstitial lung disease U Schmid, B Weber, C Sarr, M Freiwald BMC Pulmonary Medicine 21 (1), 244, 2021 | 11 | 2021 |
Exposure-efficacy analyses of nintedanib in patients with chronic fibrosing interstitial lung disease U Schmid, B Weber, MO Magnusson, M Freiwald Respiratory Medicine 180, 106369, 2021 | 10 | 2021 |
Model evaluation of continuous data pharmacometric models: metrics and graphics. CPT Pharmacometrics Syst Pharmacol 6: 87–109 THT Nguyen, MS Mouksassi, N Holford, N Al-Huniti, I Freedman, ... | 10 | 2017 |